AT-527 is a potent in vitro replication inhibitor of SARS-CoV-2, the virus responsible for the COVID-19 pandemic
S. S. Good, J. Westover, K. H. Jung, P. La Colla, G. Collu, A. Moussa, B. Canard, J.-P. Sommadossi
The paper reports that AT-511, a form of AT-527, is a potent in vitro inhibitor of SARS-CoV-2 replication with low cytotoxicity.
bioRxiv · Aug 11, 2020 · PreprintPharmacology & Toxicology